Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 91.21M | 102.74M | 110.82M | 106.02M | 87.85M |
Gross Profit | 48.77M | 56.70M | 62.53M | 59.66M | 46.04M |
EBITDA | 6.32M | -2.31M | 12.43M | 10.80M | 5.10M |
Net Income | 344.00K | -8.46M | 5.55M | 3.24M | -735.00K |
Balance Sheet | |||||
Total Assets | 102.39M | 88.65M | 104.50M | 94.57M | 89.93M |
Cash, Cash Equivalents and Short-Term Investments | 10.90M | 888.00K | 1.68M | 7.62M | 11.59M |
Total Debt | 29.92M | 16.62M | 18.12M | 13.77M | 18.16M |
Total Liabilities | 46.83M | 33.66M | 37.82M | 32.62M | 34.22M |
Stockholders Equity | 55.56M | 54.99M | 66.68M | 61.95M | 55.71M |
Cash Flow | |||||
Free Cash Flow | -1.63M | 6.67M | -6.27M | 1.15M | 4.45M |
Operating Cash Flow | 6.00K | 9.60M | -240.00K | 6.50M | 7.20M |
Investing Cash Flow | -1.64M | -2.92M | -6.58M | -4.56M | -3.28M |
Financing Cash Flow | 11.65M | -7.38M | 670.00K | -5.93M | 6.52M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | 53.63M | 7.59 | ― | 10.12% | -7.42% | -42.84% | |
74 Outperform | 49.20M | 7.75 | 18.44% | 0.62% | 2.64% | 23.89% | |
70 Neutral | 67.29M | 50.00 | 1.95% | 1.39% | 9.26% | 31.71% | |
46 Neutral | £16.20M | 186.51 | 0.17% | 2.98% | -3.72% | ― | |
45 Neutral | 34.62M | -2.26 | -22.17% | 3.12% | -7.59% | -285.33% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
Portmeirion Group PLC reported a 2.8% increase in sales at constant currency for the first half of 2025, with a notable 10.8% growth excluding the USA. The company faced significant challenges due to US import tariffs, prompting strategic adjustments such as accelerating its UK onshoring initiative and revising its US sales strategy. Despite these challenges, the company saw strong growth in South Korea and international markets, with Wax Lyrical performing well in the UK. The company is optimistic about modest sales growth in the second half of the year, driven by improvements in South Korea and international markets, while maintaining a cautious outlook for the US market.